Amgen at hold by Jefferies

Amgen Inc. was rated at hold by Jefferies & Co., Inc. analyst Adam Walsh in anticipation of the company's earnings call on Thursday. Jefferies forecasts first-quarter 2006 total revenue and earnings per share of $3.3 billion and $0.89, respectively. Shares of the Thousand Oaks, Calif., biotechnology company were up $1.35, or 1.95%, at $70.96 on volume of 10,257,423 shares versus the three-month running average of 10,848,400 shares. (Nasdaq: AMGN)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.